Fundz

Celltrion acquires iQone Healthcare Switzerland to strengthen European expansion

Nov 14, 2024

Acquiring Company

Celltrion

Acquired Company

iQone Healthcare Switzerland

IncheonVersoixManufacturingBiotechnologyTherapeuticsPharmaceuticalBiopharmaBiotechnologyHealth CarePharmaceutical

Description

Celltrion, a global biopharmaceutical leader, has announced the acquisition of iQone Healthcare Switzerland, a specialty pharmaceutical company focused on distribution, sales, and marketing in Switzerland. This acquisition represents a significant milestone in Celltrion’s European expansion strategy, providing access to in-licensing opportunities and further strengthening its pipeline of innovative therapies.

Who to call at Celltrion, and when

When Celltrion changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Celltrion raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Celltrion, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Celltrion. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Celltrion

Location

Incheon, Seoul, South Korea

About

Celltrion is a leading biopharmaceutical company based in Incheon, South Korea that specialises in researching, developing, manufacturing, marketing and sales of innovative therapeutics that improve people's lives worldwide. The company’s solutions include world-class monoclonal antibody biosimilars such as Remsima®, Truxima® and Herzuma®, providing broader patient access globally. Celltrion has also received U.S. FDA and EC approval for several products, enhancing its portfolio in the biopharmaceutical industry.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Celltrion makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Sooyoung
Likely contact at this company
••••••••@••••••••

See Sooyoung's verified email →

Jerome(Jaewoong)
Likely contact at this company
••••••••@••••••••

See Jerome(Jaewoong)'s verified email →

Naresh
Likely contact at this company
••••••••@••••••••

See Naresh's verified email →

Claudette
Senior decision-maker at this company
••••••••@••••••••

See Claudette's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Celltrion's next move

Learn about Strategic plan

Frequently asked

Who acquired iQone Healthcare Switzerland?

iQone Healthcare Switzerland was acquired by Celltrion, based in Incheon. The deal was reported on November 14, 2024. Celltrion is privately held and operates in Manufacturing.

When did Celltrion acquire iQone Healthcare Switzerland?

Celltrion's acquisition of iQone Healthcare Switzerland was reported on November 14, 2024. Celltrion, a global biopharmaceutical leader, has announced the acquisition of iQone Healthcare Switzerland, a specialty pharmaceutical company focused on distribution, sales, and marketing in Switzerland. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does iQone Healthcare Switzerland do?

iQone Healthcare Switzerland is an independent Swiss specialty pharma company focussing on the commercialisation of biosimilars, orphan drugs and oncology products. It is privately held, operating in Biotechnology, and is based in Versoix.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.